2075-1230

Tuberculosis and lung diseases

LLC "Medical Knowledge and Technologies"

View prefix report (10.58838)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 660 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact660 DOIs
2

Add abstracts to 426 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact426 DOIs
3

Deposit reference lists for 301 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Medium impact301 DOIs

DOIs for this ISSN

Showing the top 5 of 819 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 INCIDENCE, MORTALITY AND PREVALENCE AS INDICATORS OF TUBERCU… (10.21292/2075-1230-2017-95-7-8-16)
Abstract References ORCID License
178.53 60
2 EFFICIENCY AND SAFETY OF CHEMOTHERAPY REGIMEN WITH SQ109 IN… (10.21292/2075-1230-2018-96-3-6-18)
Abstract References ORCID License
154.41 34
3 MULTI DRUG RESISTANT TUBERCULOSOS IN THE COUNTRIES OF THE OU… (10.21292/2075-1230-2017-95-11-5-17)
Abstract References ORCID License
144.72 27
4 INCIDENCE, MORTALITY AND PREVALENCE AS INDICATORS OF TUBERCU… (10.21292/2075-1230-2017-95-6-9-21)
Abstract References ORCID License
143.14 26
5 EXTRAPULMONARY TUBERCULOSIS – MORE QUESTIONS THAN ANSWERS (10.21292/2075-1230-2017-95-2-59-63)
Abstract References ORCID License
141.50 25
6 TUBERCULOSIS EPIDEMIC SITUATION AMONG HIV POSITIVE PEOPLE IN… (10.21292/2075-1230-2017-95-3-13-19)
Abstract References ORCID License
136.17 22
7 MONITORING OF SPECIES DIVERSITY OF NON-TUBERCULOSIS MYCOBACT… (10.21292/2075-1230-2017-95-5-54-59)
Abstract References ORCID License
136.17 22
8 PROFILE AND RISK FACTORS OF ADVERSE REACTIONS IN NEW TUBERCU… (10.21292/2075-1230-2017-95-6-22-29)
Abstract References ORCID License
134.24 21
9 TUBERCULOSIS WITH CONCURRENT HIV INFECTION IN THE RUSSIAN FE… (10.21292/2075-1230-2017-95-9-8-18)
Abstract References ORCID License
125.53 17
10 ADVERSE EVENTS DURING TREATMENT OF PATIENTS SUFFERING FROM M… (10.21292/2075-1230-2018-96-3-35-43)
Abstract References ORCID License
125.53 17
11 EXTRAPULMONARY TUBERCULOSIS IN HIV PATIENTS (10.21292/2075-1230-2017-95-11-19-25)
Abstract References ORCID License
120.41 15
12 WHO GLOBAL TUBERCULOSIS REPORTS: COMPILATION AND INTERPRETAT… (10.21292/2075-1230-2017-95-5-7-16)
Abstract References ORCID License
120.41 15
13 THE NIDUS OF TUBERCULOUS INFECTION AS A RISK FACTOR OF MULTI… (10.21292/2075-1230-2018-96-1-11-17)
Abstract References ORCID License
117.61 14
14 THE POSTPONED TREATMENT OUTCOMES IN PULMONARY TUBERCULOSIS P… (10.21292/2075-1230-2018-96-3-24-28)
Abstract References ORCID License
117.61 14
15 EXPERIENCE OF USING BEDAQUILINE IN THE MULTIMODALITY THERAPY… (10.21292/2075-1230-2017-95-9-49-54)
Abstract References ORCID License
114.61 13
16 IMPACT OF HIV INFECTION ON THE STRUCTURE OF NEW TUBERCULOSIS… (10.21292/2075-1230-2017-95-10-17-26)
Abstract References ORCID License
111.39 12
17 THE EFFECT OF DIFFERENT TB DRUGS AND ANTIMICROBIAL AGENTS ON… (10.21292/2075-1230-2017-95-10-9-15)
Abstract References ORCID License
111.39 12
18 EXPERIENCE OF USING BEDAQUILINE IN THE TREATMENT OF PULMONAR… (10.21292/2075-1230-2017-95-12-49-53)
Abstract References ORCID License
111.39 12
19 DIFFERENTIAL DIAGNOSTICS OF TUBERCULOSIS AND MYCOBACTERIOSIS… (10.21292/2075-1230-2017-95-10-47-52)
Abstract References ORCID License
107.92 11
20 TUBERCULOSIS IN SIBERIAN AND FAR EASTERN FEDERAL DISTRICTS (… (10.21292/2075-1230-2017-95-8-12-17)
Abstract References ORCID License
104.14 10
21 IN VITRO PHOTODYNAMIC INACTIVATION OF MYCOBACTERIUM TUBERCUL… (10.21292/2075-1230-2018-96-1-5-10)
Abstract References ORCID License
104.14 10
22 EFFICIENCY OF CHEMOTHERAPY WITH BEDAQUILINE IN DRUG RESISTAN… (10.21292/2075-1230-2018-96-2-22-26)
Abstract References ORCID License
104.14 10
23 TO DISCONTINUE OR TO WAIT?: INDICATIONS FOR DISCONTINUATION… (10.21292/2075-1230-2018-96-2-47-54)
Abstract References ORCID License
104.14 10
24 IMPACT OF HIV INFECTION ON THE INTENSITY OF TUBERCULOSIS EPI… (10.21292/2075-1230-2018-96-2-5-10)
Abstract References ORCID License
104.14 10
25 FREQUENCY OF DETECTION AND SPECIFIC MORPHOLOGY OF NON-TUBERC… (10.21292/2075-1230-2016-94-12-57-61)
Abstract References ORCID License
100.00 9
26 INDIVIDUAL APPROACHES TO THE CHOICE OF CHEMOTHERAPY REGIMENS… (10.21292/2075-1230-2016-94-9-24-29)
Abstract References ORCID License
95.42 8
27 MULTIDISCIPLINARY APPROACH TO SUPPORTING TREATMENT COMPLIANC… (10.21292/2075-1230-2017-95-1-34-41)
Abstract References ORCID License
95.42 8
28 FREQUENCY AND CHARACTERISTICS OF ADVERSE REACTIONS TO SECOND… (10.21292/2075-1230-2017-95-10-63-67)
Abstract References ORCID License
95.42 8
29 DETECTION OF NON-TUBERCULOUS MYCOBACTERIA IN MARI EL REPUBLI… (10.21292/2075-1230-2018-96-2-41-46)
Abstract References ORCID License
95.42 8
30 ANTERIOR MEDIASTINAL PLASTICS DURING PNEUMONECTOMY AS PREVEN… (10.21292/2075-1230-2017-95-11-36-40)
Abstract References ORCID License
90.31 7
31 CHANGES IN THE PREVALENCE OF DRUG RESISTANT TUBERCULOSIS (10.21292/2075-1230-2017-95-3-5-12)
Abstract References ORCID License
90.31 7
32 IMPACT OF MEDICAL AND SOCIAL FACTORS ON SURGICAL OUTCOMES OF… (10.21292/2075-1230-2018-96-2-11-15)
Abstract References ORCID License
90.31 7
33 INDIVIDUAL TREATMENT OF PULMONARY MDR/XDR TUBERCULOSIS IN AD… (10.21292/2075-1230-2018-96-2-55-63)
Abstract References ORCID License
90.31 7
34 EFFICIENCY OF VALVE BRONCHIAL BLOCK WITHIN COMPREHENSIVE TRE… (10.21292/2075-1230-2018-96-4-47-51)
Abstract References ORCID License
90.31 7
35 HIV INFECTION AS A RISK FACTOR OF TUBERCULOSIS IN CHILDREN (10.21292/2075-1230-2017-95-1-18-21)
Abstract References ORCID License
84.51 6
36 THORACOPLASTY WITH POLYPROPYLENE MESH IN PULMONARY TUBERCULO… (10.21292/2075-1230-2017-95-12-6-9)
Abstract References ORCID License
84.51 6
37 EXTRAPULMONARY TUBERCULOSIS IN SIBERIA AND FAR EAST (10.21292/2075-1230-2017-95-3-24-27)
Abstract References ORCID License
84.51 6
38 DETECTION OF TUBERCULOUS MYCOBACTERIA IN SPUTUM AND INTENSIT… (10.21292/2075-1230-2017-95-7-17-23)
Abstract References ORCID License
84.51 6
39 RISK ASSESSMENT AND MONITORING OF HEPATOTOXIC REACTIONS IN T… (10.21292/2075-1230-2017-95-9-40-48)
Abstract References ORCID License
84.51 6
40 USE OF ENDOBRONCHIAL VALVES AND EXTRAPLEURAL SEALING FOR TRE… (10.21292/2075-1230-2017-95-9-60-67)
Abstract References ORCID License
84.51 6
41 EXTRAPULMONARY TUBERCULOSIS: CLINICAL EPIDEMIOLOGICAL CHARAC… (10.21292/2075-1230-2018-96-6-22-28)
Abstract ORCID License
78.10 10
42 SURGICAL TREATMENT OF PULMONARY TUBERCULOSIS IN HIV POSITIVE… (10.21292/2075-1230-2016-94-12-53-56)
Abstract References ORCID License
77.82 5
43 MYCOBACTERIOSIS IN THE PRACTICE OF PULMONOLOGISTS AND PHTHIS… (10.21292/2075-1230-2016-94-9-39-43)
Abstract References ORCID License
77.82 5
44 IN VITRO ACTION OF THE DRUG CANDIDATE OF PBTZ169, HYDROCHLOR… (10.21292/2075-1230-2016-94-9-73-79)
Abstract References ORCID License
77.82 5
45 EXPERIENCE OF USING TB-TEST TECHNOLOGY (BIOCHIP-IMB, RUSSIA)… (10.21292/2075-1230-2017-95-10-29-35)
Abstract References ORCID License
77.82 5
46 EFFICIENCY OF PULMONARY TUBERCULOSIS CHEMOTHERAPY IN NEW CAS… (10.21292/2075-1230-2017-95-11-63-66)
Abstract References ORCID License
77.82 5
47 MEDICAL AND SOCIAL UNFAVORABLE FACTORS IN THOSE WITH TB/HIV… (10.21292/2075-1230-2017-95-12-35-38)
Abstract References ORCID License
77.82 5
48 THE INTENSITY OF SYSTEMIC INFLAMMATION RESPONSE IN THOSE SUF… (10.21292/2075-1230-2017-95-6-36-40)
Abstract References ORCID License
77.82 5
49 EFFECTIVENESS OF COMBINATION OF ISONIAZID AND SILVER NANOPAR… (10.21292/2075-1230-2017-95-6-51-58)
Abstract References ORCID License
77.82 5
50 DETECTION AND DIFFERENTIAL DIAGNOSTICS OF TUBERCULOSIS IN CH… (10.21292/2075-1230-2017-95-9-34-39)
Abstract References ORCID License
77.82 5